PubMed · 2367030
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
N K Tamarisk. 1990. Personal computer databases for middle managers.. https://pubmed.ncbi.nlm.nih.gov/2367030/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
To assess the procedural results after coronary angioplasty using the transluminal extraction catheter (TEC) in patients with complex lesion anatomy, experience with 51 patients undergoing this procedure was reviewed. One or more adverse lesion morphologic features were present in 45 patients (88%) and > or = 2 adverse features were present in 38 (74%). Procedural success (< 50% final diameter stenosis and the absence of major complications) was obtained in 42 patients (82%); major complications occurred in 7 patients (death, 3; Q-wave myocardial infarction, 4; emergency bypass operation, 2). Distal embolization was noted in 5 patients with thrombus-containing saphenous vein graft stenoses. Only lesion thrombus correlated with an unsuccessful outcome. After TEC use, diameter stenosis was reduced from 76 +/- 13 to 50 +/- 22% (p < 0.001). Adjunct balloon angioplasty was used in 44 procedures (86%), further reducing the diameter stenosis to 32 +/- 22% (p < 0.001 compared with post-TEC). High-frequency intracoronary ultrasound was performed in 11 patients after TEC use. Plaque fissuring was present in all lesions and intraluminal dissection was noted in 4 (36%). Residual plaque after TEC use was found in virtually all lesions. During the 5.2 +/- 2.8-month follow-up period, 17 patients (40%) developed recurrent symptoms. Coronary bypass surgery was performed in 4 patients and repeat coronary angioplasty was required in 3. In addition, 3 patients died from cardiac causes. It is concluded that coronary angioplasty using the TEC may be a useful alternative to balloon angioplasty in patients with complex coronary anatomy, although distal embolization may still occur in thrombus-containing saphenous vein graft lesions.
The role of excimer laser angioplasty in treating complex coronary artery disease remains uncertain. A randomized trial comparing this new technology with balloon angioplasty cannot be designed until systematic analysis identifies the lesion types that are likely to benefit from treatment with excimer laser angioplasty. In a cohort of 764 patients who had 858 coronary stenoses treated with excimer laser-facilitated angioplasty, relative risk analysis was used to examine acute success, complications and restenosis rates, and the results were compared with those of balloon angioplasty to identify the lesion types that show the greatest benefit with the new treatment. Clinical success was achieved in 657 patients (86%), as indicated by < or = 50% residual stenosis and no in-hospital complication. A major in-hospital complication (death, bypass surgery, or Q-wave or non-Q-wave myocardial infarction) occurred in 58 patients (7.6%). Follow-up angiography was obtained in 70% of eligible patients. Combining angiographic and noninvasive restenosis rates yielded an overall restenosis rate of 46%. Relative risk analysis showed that major complications occurred frequently in lesions at an arterial bifurcation (odds ratio [OR] 5.96 [2.76, 12.6]; p = 0.001). However, certain complex lesions that are difficult to treat with balloon angioplasty (saphenous vein graft lesions, lesions > 10 mm, ostial lesions, calcified stenoses, total occlusions and unsuccessful balloon dilatations), analyzed together as a group, had lower complication rates by univariate (OR 0.59 [0.35, 1.00]; p = 0.051) and multivariate logistic regression (p = 0.006) analyses.(ABSTRACT TRUNCATED AT 250 WORDS)